마이타케 프로4x D-Fraction 농축액 / Grifron Pro 4x D-fraction Liquid


마이다케 프로 4x D-Fraction 농축액 은 일반 D-Fraction 추출용액 의 4배 농축액 입니다.


[ Ingredients ] 용량및 함량
Serving Size: 6 drops
Servings per Container: 270
Amount per Serving:
Maitake Mushroom (Grifola frondosa) Extract
(PD-Fraction™, standardized to contain 30% active proteoglucan) 22 mg*
Other Ingredients:
Water, Vegetable Glycerine

*Daily Value not established.




[ Direction for Use ]
For health maintenance, take 6 drops three times a day or as directed by your practitioner.
건강유지 일경우 는 매일 3회 6 방울씩 드시고

For the best benefit we recommend to take 1 drop/kg of body weight daily, divided into 3 doses.

집중적 섭취 / 대체요법 의 경우
1회 섭취량 은 몸무게 1 kg 당 1방울 을 하루섭취량 으로 계산 합니다

즉 체중 60 kg 은 60 방울 / 3회 = 1회 20 방울씩 하루 3회 드십니다. ,

[Examples]
Are you familiar with kg?
If you weigh 75kg, take 75 drops divided in 3 times (25 drops x 3 times) a day.
Are you not familiar with kg?
If you weigh 150 lb, divide it by 2 (=75). That approximates kg. Take 75 drops a day.

마이다케

2005.05.09

미국정부 기금출연 암연구기관 으로 뉴욕에 위치한 메모리알 슬로안-케터링 암센터
(MSKCC) 에서 의 연구결과 발표는 마이타케 버섯추출물 임상시험 1/II 상 결과,
다음 단계로 유방암 1,2 3기 암제거 수술환자 에게 마이타케 추출물 의 독성이나
부작용 없이 면역력 증강을 확인 하는 다음단계 임상시험 을 진행 한다고 발표함

Memorial Sloan-Kettering Now Engaged in Clinical Trial On Breast Cancer Patients using Maitake Extract In a government-funded cancer research, Memorial Sloan-Kettering Cancer Center (MSKCC) in New York City has announced in its website that a phase I/II clinical study of Maitake extract is now underway against women who had stage I, II or III breast cancer that was surgically removed. The study is being conducted at MSKCC in collaboration with The New York Presbyterian Hospital-Weill Medical College of Cornell University, to determine if Maitake extract can stimulate the immune without causing any side effects or toxicity

2005.01.20


Maitake D-Fraction® Appears in American Cancer Societyís Guide to Complementary and Alternative Cancer Methods
In response to rising interest among American public in complementary and alternative methods for treating cancer, the American Cancer Society has published two guidebooks to such treatments, both including a section on Maitake D-Fraction®. Maitake D-Fraction® is the flagship product of Maitake Products, Inc. and has been on the dietary supplement market since 1995.



과학자들은 D-fraction이 T 세포와 자연적인 킬러세포들을 활성화시킨다고 믿고 있다.
게다가 그 버섯추출물은 암과 화학치료요법에 의한 고통, 탈모, 메스꺼움 같은
증상들을 완화시켜 주는 역할도 한다.



[ Product Description ]
Grifron®-Pro Maitake D-Fraction® (Tincture) contains purified and standardized "active proteoglucan" from Maitake mushroom (Grifola frondosa) with professional strength.

The "Grifron®-Pro" products are the most purified and concentrated version among our D-Fraction line.

The active proteoglucan, often referred to as D-fraction by scientists, is a unique beta-glucan conjugated with protein, which has been identified and isolated as a responsible substance for potent immune-activating property of Maitake mushroom.*

Grifron®-Pro Maitake D-Fraction® has been the subject of many clinical and non-clinical studies in the US, Japan and other countries. It was honored to be referred to by many prominent healthcare professionals in their books and articles repeatedly. Our studies and marketing history show that it is very safe and well tolerated.

Grifron®-Pro Maitake D-Fraction® 2 oz. bottle contains 6,000 mg of PD-Fraction, which is standardized to contain more than 1,800 mg (30%) of the active proteoglucan.

(Please note that other maitake extract products on the market contain no more than 2,000 mg of crude extracts in 2 oz. Further, the levels of active substances in such crude extracts have never been disclosed.)

Grifron®-Pro Maitake D-Fraction® contains no alcohol, sugar, yeast, mold, gluten, dairy products, artificial colors, preservatives, pesticides, herbicides or fertilizers.

Maitake D-Fraction® is the registered trademark of Maitake Products, Inc. which holds the exclusive right to use the trade name.

*These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.